INDIAGLYCO — India Glycols Balance Sheet
0.000.00%
- IN₹66.24bn
- IN₹82.25bn
- IN₹98.27bn
Annual balance sheet for India Glycols, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 70.5 | 19.7 | 270 | 68.4 | 889 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7,818 | 7,483 | 6,750 | 5,549 | 3,635 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 16,072 | 16,462 | 19,447 | 18,162 | 14,978 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 25,518 | 28,321 | 32,803 | 39,243 | 45,880 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 46,307 | 48,583 | 56,168 | 61,761 | 65,230 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 17,487 | 18,649 | 23,747 | 23,210 | 20,141 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 28,388 | 29,569 | 35,658 | 39,202 | 35,902 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 17,919 | 19,014 | 20,510 | 22,559 | 29,328 |
| Total Liabilities & Shareholders' Equity | 46,307 | 48,583 | 56,168 | 61,761 | 65,230 |
| Total Common Shares Outstanding |